Nice to see this all important trial that will help partnering discussions, prove DMOAD and is critical to Provisional Approval timelines is de-risked by being a multi-site and that patient convenience was assessed before the trial began.
research reports and media, page-1908
-
- There are more pages in this discussion • 2,280 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
-0.010(3.23%) |
Mkt cap ! $103.1M | |||
| Open | High | Low | Value | Volume |
| 31.0¢ | 31.5¢ | 29.0¢ | $133.5K | 434.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 12472 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.5¢ | 1298 | 3 |
View Market Depth
| Last trade - 14.50pm 15/07/2024 (20 minute delay) ? |
| PAR (ASX) Chart |